Hims & Hers Health (HIMS)
(Delayed Data from NYSE)
$62.55 USD
-3.63 (-5.49%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $62.51 -0.04 (-0.06%) 7:58 PM ET
1-Strong Buy of 5 1
D Value A Growth F Momentum C VGM
Fundamental Charts
About PEG Ratio (TTM)
Currently, Hims & Hers Health, Inc. has a PEG ratio of 4.24 compared to the Medical Info Systems industry's PEG ratio of 2.78.
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
HIMS 62.55 -3.63(-5.49%)
Will HIMS be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for HIMS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for HIMS
Hims & Hers Stock to Report Q2 Earnings: What's in the Cards?
Fulgent Genetics, Inc. (FLGT) Surpasses Q2 Earnings and Revenue Estimates
HIMS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Hims & Hers Leads the Charge in AI-Powered Personalized Healthcare
Earnings Preview: Evolent Health (EVH) Q2 Earnings Expected to Decline
Pulmonx Corporation (LUNG) Reports Q2 Loss, Beats Revenue Estimates
Other News for HIMS
HIMS Stock Faces Mixed Sentiment Ahead of Earnings Report
Option traders moderately bearish in Hims and Hers Health with shares down 5.67%
Hims & Hers Health Inc (HIMS) Faces Class Action Lawsuit Over Alleged Misconduct | HIMS ...
Hims & Hers Health Earnings Preview
EXCLUSIVE: July's 20 Most-Searched Tickers On Benzinga Pro — Where Do Opendoor, Nvidia, Apple Stock Rank?